Entrada Therapeutics (TRDA) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.73
0.03
0.79
1.55

Details

Expected EPS
-0.728
Actual EPS
-0.35
Surprise EPS
0.38
Surprise Percent
+51.92%

Description

Entrada Therapeutics (TRDA) has reported earnings of -0.35 per share for Q4 2024.

0 Comments

Share your thoughts